Rare diseases
Investigational molecules
Locations
A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GermanyStudy of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo
GermanyComparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease
GermanyStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
GermanyStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
GermanyStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
GermanyStudy of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals
GermanyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GermanyStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
GermanyLong-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial
GermanyStudy of orforglipron in people with high blood pressure who are overweight or have obesity
GermanyComparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
